Table 2.
Resistance-Associated Mutations by Gene Location and Study Visit for Plasma Specimens
|
Patients with RAMs, n (%) |
|
---|---|---|
Resistance-associated mutation | Enrollment (N = 55) | 6–12 weeks (N = 97) |
Reverse transcriptase | ||
M184V | 1 (1.8) | 5 (5.2) |
M41L | 1 (1.8) | 2 (2.1) |
D67N | 0 | 1 (1.0) |
K70R | 2 (3.6) | 5 (5.2) |
L210W | 1 (1.8) | 0 |
K219Q | 0 | 1 (1.0) |
V75I | 0 | 0 |
K103N | 1 (1.8) | 3 (3.1) |
V118I | 2 (3.6) | 1 (1.0) |
G190A | 0 | 0 |
E44D | 1 (1.8) | 0 |
V118I | 1 (1.8) | 0 |
V179D | 0 | 2 (2.1) |
Protease | ||
D30N | 1 (1.8) | 1 (1.0) |
L33F | 0 | 0 |
M46I | 2 (3.6) | 1 (1.0) |
V82A | 0 | 1 (1.0) |